Original air date: September 27, 2016. Patent Exhaustion: a review of Lexmark and patent licensing strategies that apply to the biotechnology industry in view of recent patent exhaustion case law.
This webinar will first discuss international exhaustion and the first sale doctrine in view of the 2016 en banc Federal Circuit decision in
Lexmark International, Inc. v. Impression Products, Inc. The webinar will then cover patent exhaustion pitfalls for the unwary that apply to patent licensing in the biotechnology industry, including licensing strategies that take into account the possibility that the Supreme Court will overturn or limit
Lexmark regarding the restricted sales exception to patent exhaustion. Presented by:
Ron Kamis of Prismatic Law Group, PLLC;
Jeremy McKown of Johnson & Johnson; moderated by
Eric Silverman of 3M.